Lisa Ricciardi
President/ Chief Executive Officer & Board Member at Cognition Therapeutics, Inc. | New York City Metropolitan Area, United States
Lisa Ricciardi’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
President/ Chief Executive Officer & Board Member at Cognition Therapeutics, Inc. in June 2019 - Present
US and International Public Board Director Roles at Various Biopharmaceutical Companies in January 2007 - Present
Executive In Residence at Columbia Technology Ventures in January 2020 - June 2020
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company leveraging two decades of mechanistic, translational, and clinical research to deliver effective treatments for neurodegenerative diseases affecting millions of families. We are building on breakthroughs in well-established biological pathways underlying neurodegeneration, to lead the charge in developing accessible, novel small-molecule therapies for age-related degenerative diseases that have historically been understudied, underserved, and misunderstood. Zervimesine (CT1812) is Cognition Therapeutics’ investigational first-in-class oral therapy. The goal of treatment is to protect brain synapses before irreversible neuronal decline occurs, which may offer an accessible solution for people with neurodegenerative diseases, such as dementia with Lewy bodies (DLB) and Alzheimer’s disease. Led by a dedicated and nimble team headquartered in Purchase, NY, our work is driven by a deep commitment to supporting patients and caregivers impacted by these challenging diseases.
Discover more about Cognition Therapeutics, Inc.President and CEO, Supernus Pharmaceuticals, Inc.
Chairman, Board of Directors at scPharmaceuticals
(July 2016 – Present)
Director of Clinical Operations | Cognition Therapeutics | Global Trial Leadership | Driving Excellence in Study Design, Execution & Partnerships to Deliver Next-Generation Neurology Therapies
Lead a team of 9 Project Managers, Clinical Trial Assistants and TMF Specialists executing 3 neurodegeneration clinical trials representing $200M
• Provide weekly executive updates to support real-time decision-making, improving milestone adherence by a combined 80%
• Faci...
Board Member, Audit Chair, Global Executive, NACD Certified Director
Board Of Directors, Audit Chair at Cognition Therapeutics, Inc.
(Nov 2021 – Present)
Dobbs Ferry, NY
Vice President, Head of Clinical Development at Cognition Therapeutics, Inc.
(Feb 2026 – Present)
Vice President, Clinical Operations
Vice President Clinical Operations at Cognition Therapeutics, Inc.
(Jan 2024 – Present)
Neuroscience Research - Medical Affairs - Communications and Publications Consultant - Biomarkers and Drug Development
Proteomics biomarker research, publications planning, and scientific writing for clinical-stage neuroscience company developing therapeutics intended to treat neurodegenerative disorders.
What is Lisa Ricciardi email address?
Email Lisa Ricciardi at [email protected], [email protected] and [email protected]. This email is the most updated Lisa Ricciardi's email found in 2026.
How to contact Lisa Ricciardi?
To contact Lisa Ricciardi send an email to [email protected], [email protected] or [email protected].
What company does Lisa Ricciardi work for?
Lisa Ricciardi works for Cognition Therapeutics, Inc..
What is Lisa Ricciardi's role at Cognition Therapeutics, Inc.?
Lisa Ricciardi is President/ Chief Executive Officer & Board Member
What industry does Lisa Ricciardi work in?
Lisa Ricciardi works in the Pharmaceuticals industry.